360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Levemir

Type: Product

Name: Levemir

First reported May 08 2013 - Updated May 08 2013 - 2 reports

SITAGLIPTIN

Merck & Co., Inc. (MRK), Novo Nordisk A/S (ADR) (NVO): Who Should You Buy?

Recently, I have focused in on some companies that play a major role in diabetic’s lives like mine. The financial implications of this disease are astounding, and have presented what seems to be a great opportunity for investors. Today, I will discuss ... [Published InsiderMonkey.com - May 08 2013]

Entities: SITAGLIPTIN, NOVO NORDISK A/S, Merck & Co Inc

First reported May 01 2013 - Updated May 02 2013 - 2 reports

Very strong quarter for Novo despite Tresiba setback in USA

Novo Nordisk has posted yet another stellar set of figures, helped by strong sales of its diabetes drug Victoza.First-quarter net profit climbed 28% to 5.98 billion Danish kroner (about $1.06 billion), while sales were up 13% to 19.98 billion kroner. ... [Published Pharma Times - May 01 2013]

Entities: Tresiba, Insulin, Victoza

First reported May 01 2013 - Updated May 01 2013 - 2 reports

Novo Nordisk and EMIS Modify Deal - Analyst Blog

Novo Nordisk A/S (NVO) and Emisphere Technologies, Inc. (EMIS) recently announced that they have modified their agreement for the development and commercialization of oral formulations of Novo Nordisk's proprietary GLP-1 receptor agonist candidates for ... [Published Quote.com South Africa - May 01 2013]

Entities: NOVO NORDISK A/S, NovoRapid, Levemir, GLP-1, Victoza

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Novo Nordisk Q1 Profit Climbs - Quick Facts

Dutch drug maker Novo Nordisk A/S (NVO: Quote) posted higher first-quarter net profit of 5.98 billion Danish kroner, or 10.98 Danish kroner a share, compared with 4.66 billion Danish kroner, or 8.32 Danish kroner a share a year before. Quarterly operating ... [Published RTTNews.com - May 01 2013]

Entities: NOVO NORDISK A/S, NovoRapid, Levemir, Victoza

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Novo Nordisk A/S increased operating profit by 18% in the first quarter of 2013

Sales growth of 13% driven by Victoza®, NovoRapid® and Levemir [HUG#1698229] ... [Published NASDAQ OMX - May 01 2013]

Entities: NOVO NORDISK A/S, NovoRapid, Levemir

First reported May 01 2013 - Updated May 01 2013 - 1 reports

NOVO NORDISK A/S

Novo Nordisk A/S increased operating profit by 18% in the first quarter of 2013

Less than a minute ago, 1:45am (ET) 05/01/2013 MarketwireFinancial report for the period 1 January 2013 to 31 March 2013. Sales growth of 13% driven by Victoza(R), NovoRapid(R) and LevemirCompany announcement No 32 / 2013: http://hugin.info/2013/R/16 ... [Published Zecco - May 01 2013]

Entities: NOVO NORDISK A/S, Mike Rulis, US 1 Industries Inc

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Sorry Charlie! Novo's Race with Insulin "Chain E-mail" Sweepstakes Campaign is Spam

I once characterized a @Racewithinsulin Levemir branded tweet as "Sleazy Twitter Spam" (search Google on "race with insulin spam" and you'll find this post ). That got a lot of comments from people arguing that the tweet wasn't technically "spam."Today, ... [Published Pharma Marketing Blog - Apr 25 2013]

Entities: Spam, Insulin, Levemir, NOVO NORDISK A/S, FlexPen

First reported Mar 19 2013 - Updated Mar 19 2013 - 1 reports

Rx Promo Spending Ebbed With Industry Woes

As the first decade of the 21st century began, the pharmaceutical industry was spending a lot of dollars to promote its drugs. By 2004, $36 billion was spent to reach consumers and physicians, up from $26.3 billion just three years earlier. But thanks ... [Published Pharmalot - Mar 19 2013]

Entities: Biology, Drugs, Declination, Levemir, SIMPONI

First reported Jan 08 2013 - Updated Jan 08 2013 - 1 reports

Team Novo Nordisk: Insulin "Doping" Difficult to Prove

Novo Nordisk has a penchant for teaming up with athletes to help promote its diabetes franchise. You might recall that in the U.S. Novo Nordisk's Levemir insulin brand team sponsors Charlie Kimball, a racecar driver who has diabetes ( see here ). Just ... [Published Pharma Marketing Blog - Jan 08 2013]

Entities: NOVO NORDISK A/S, Insulin, Levemir

Quotes

CEO Lars Rebien Sørensen remarked "we are pleased with the strong sales in the first quarter...driven by our portfolio of modern insulins and Victoza." Quarterly revenue from modern insulins jumped 14 percent year-over-year to 9 billion kroner ($1...

Novo Nordisk's Q1 Profit Up 28 Percent [Published PharmaceuticalProcessing - May 01 2013]

...Mr Sorensen said "we are in a constructive dialogue with the FDA on how to resolve the issues raised" in the CRLs

Very strong quarter for Novo despite Tresiba setback in USA [Published Pharma Times - May 01 2013]

...item: When you sign up and supply your friends' e-mail addresses, Novo does not tell you that the e-mail "ivies" that your friends will receive "MAY CONTAIN MATERIAL MARKETING OR ADVERTISING NOVO NORDISK PRODUCTS, GOODS, OR SERVICES." The entry screen (see below) only refers to the e-mail messages YOU receive

Sorry Charlie! Novo's Race with Insulin "Chain E-mail" Sweepstakes Campaign is Spam [Published Pharma Marketing Blog - Apr 25 2013]

More Content

sort by: Date \| Relevance
Diabetes drugs market will reach $55.3bn in 201... [Published Prlog - May 16 2013]
Merck & Co., Inc. (MRK), Novo Nordisk A/S (ADR)... [Published InsiderMonkey.com - May 08 2013]
The Ups and Downs of Diabetes [Published Motley Fool - May 08 2013]
Earnings and Sales Rise at Novo Nordisk - Analy... [Published Quote.com India - May 02 2013]
Novo Nordisk and EMIS Modify Deal - Analyst Blog [Published Quote.com South Africa - May 01 2013]
Novo Nordisk and EMIS Modify Deal - Analyst Blog [Published Canada News Wire via Quote.com - May 01 2013]
Novo Nordisk's Q1 Profit Up 28 Percent [Published PharmaceuticalProcessing - May 01 2013]
Very strong quarter for Novo despite Tresiba se... [Published Pharma Times - May 01 2013]
Novo Nordisk First-Quarter Profit Climbs on Ins... [Published Bloomberg - May 01 2013]
Novo Nordisk Q1 Profit Climbs - Quick Facts [Published RTTNews.com - May 01 2013]
Novo Nordisk A/S increased operating profit by ... [Published NASDAQ OMX - May 01 2013]
Novo Nordisk A/S increased operating profit by ... [Published Zecco - May 01 2013]
Novo Nordisk A/S increased operating profit by ... [Published Marketwire - Breaking News Releases - May 01 2013]
Novo Nordisk A/S increased operating profit by ... [Published GlobeNewswire: Advertising News - May 01 2013]
Novo Nordisks resultat af primær drift steg med... [Published GlobeNewswire: Advertising News - May 01 2013]
Sorry Charlie! Novo's Race with Insulin "Chain ... [Published Pharma Marketing Blog - Apr 25 2013]
Colombia ex-Presidents Uribe, Pastrana investig... [Published Colombia Reports - Apr 18 2013]
Colombia considers legal amendment defining sex... [Published Colombia Reports - Apr 18 2013]
Type 2 Diabetes - Global Drug Forecasts and Tre... [Published PipelineReview - Apr 16 2013]
Colombian inmates granted excessive privileges ... [Published Colombia Reports - Apr 16 2013]
Colombia congratulates Maduro for disputed Vene... [Published Colombia Reports - Apr 16 2013]
Novo Nordiskâs Achieve study reveals low sugar ... [Published PharmaBiz - Mar 20 2013]
Rx Promo Spending Ebbed With Industry Woes [Published Pharmalot - Mar 19 2013]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published Marketwire - Breaking News Releases - Jan 31 2013]
Team Novo Nordisk: Insulin "Doping" Difficult t... [Published Pharma Marketing Blog - Jan 08 2013]
Despite Formulary, High-Cost Diabetes Drug Use ... [Published US Medicine - Nov 15 2012]

Blogs

sort by: Date \| Relevance
Sorry Charlie! Novo's Race with Insulin "Chain ... [Published Pharma Marketing Blog - Apr 25 2013] I once characterized a @Racewithinsulin Levemir branded tweet as "Sleazy Twitter Spam" (search Google on "race with insulin spam" and you'll find this post ). That got a lot of comments from people arguing that the tweet wasn't technically "spam."Today, ...
Rx Promo Spending Ebbed With Industry Woes [Published Pharmalot - Mar 19 2013] As the first decade of the 21st century began, the pharmaceutical industry was spending a lot of dollars to promote its drugs. By 2004, $36 billion was spent to reach consumers and physicians, up from $26.3 billion just three years earlier. But thanks ...
Team Novo Nordisk: Insulin "Doping" Difficult t... [Published Pharma Marketing Blog - Jan 08 2013] Novo Nordisk has a penchant for teaming up with athletes to help promote its diabetes franchise. You might recall that in the U.S. Novo Nordisk's Levemir insulin brand team sponsors Charlie Kimball, a racecar driver who has diabetes ( see here ). Just ...

Press Releases

sort by: Date \| Relevance
Novo Nordisk A/S increased operating profit by ... [Published Marketwire - Breaking News Releases - May 01 2013]
Novo Nordisk A/S increased operating profit by ... [Published GlobeNewswire: Advertising News - May 01 2013]
Novo Nordisks resultat af primær drift steg med... [Published GlobeNewswire: Advertising News - May 01 2013]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published Marketwire - Breaking News Releases - Jan 31 2013]